Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$8,107,840
+$1,384,790 QoQ
Shares Held
32,220
+4.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#1,030
of 4,152 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$50,328
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026B. Riley Wealth Advisors, Inc. holds $62,126,199 across 15 Drug Manufacturers - General names. ABBV ranks #3 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,302 | $26,749,690 | |
| 2 | JNJ |
Johnson & Johnson
|
49,143 | $12,480,847 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
32,220 | $8,107,840 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,226 | $3,755,541 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
56,350 | $3,246,887 | |
| 6 | PFE |
Pfizer Inc
|
90,498 | $2,179,191 | |
| 7 | AMGN |
Amgen Inc
|
3,654 | $1,323,186 | |
| 8 | AZN |
Astrazeneca PLC
|
4,594 | $871,114 |
All Filings in ABBV
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,107,840 | 32,220 | Shares | Sole | 2026-07-14 | |
| 2026-06-30 | $50,328 | 200 | Call | Sole | 2026-07-14 | |
| 2026-03-31 | $6,723,050 | 30,912 | Shares | Sole | 2026-04-27 | |
| 2026-03-31 | $42,624 | 20,000 | Call | Sole | 2026-04-27 | |
| 2025-12-31 | $8,569,288 | 37,504 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $45,698 | 200 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $46,308 | 20,000 | Call | Sole | 2025-10-31 | |
| 2025-09-30 | $9,032,143 | 39,009 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $7,834,648 | 42,208 | Shares | Sole | 2025-08-19 | |
| 2025-06-30 | $37,124 | 200 | Call | Sole | 2025-08-19 | |
| 2024-12-31 | $14,920,935 | 83,967 | Shares | Sole | 2025-02-25 | |
| 2024-09-30 | $17,003,028 | 86,100 | Shares | Sole | 2024-12-13 | |
| 2024-06-30 | $19,050,554 | 111,069 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $26,479,525 | 145,412 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $20,180,038 | 130,219 | Shares | Sole | 2024-03-15 | |
| 2023-09-30 | $21,675,112 | 145,412 | Shares | Sole | 2023-12-01 | |
| 2023-06-30 | $22,508,532 | 167,064 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $29,128,373 | 182,772 | Shares | Sole | 2023-05-17 | |
| 2022-06-30 | $17,617,381 | 115,026 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $20,725,762 | 127,850 | Shares | Other | 2022-05-02 | |
| 2021-12-31 | $17,298,568 | 127,759 | Shares | Other | 2022-01-28 | |
| 2021-09-30 | $13,567,564 | 125,777 | Shares | Other | 2021-11-16 | |
| 2021-06-30 | $13,127,516 | 116,544 | Shares | Other | 2021-08-10 | |
| 2021-03-31 | $11,708,861 | 108,195 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $6,989,394 | 65,230 | Shares | Other | 2021-02-04 | |
| 2020-09-30 | $7,048,978 | 80,477 | Shares | Other | 2020-11-09 | |
| 2020-06-30 | $7,767,412 | 79,114 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $4,963,320 | 65,144 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||